Medinol Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
12
Ending by 2030
Jun 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 30, 2026The maintenance fee for Apparatus and method of imaging (US 11,660,059) comes due Nov 30, 2026. Unpaid by Jun 1, 2027, it lapses early.
- 2 fees due Dec 18 to 27, 2026 · next Dec 18
- 1 fee due Jan 23, 2027The maintenance fee for Influenza Virus-Like Particle Production in Plants (US 10,358,652) comes due Jan 23, 2027. Unpaid by Jul 23, 2027, it lapses early.
- 2 fees due Feb 1 to 15, 2027 · next Feb 1
- 3 fees due Mar 3 to 29, 2027 · next Mar 3
- 4 fees due Apr 1 to 17, 2027 · next Apr 1
- 3 fees due May 7 to 28, 2027 · next May 7
- 2 fees due Jun 5 to 22, 2027 · next Jun 5
- 2 fees due Jul 16 to 30, 2027 · next Jul 16
- 1 fee due Aug 18, 2027The maintenance fee for Modified CPMV enhancer elements (US 10,563,213) comes due Aug 18, 2027. Unpaid by Feb 18, 2028, it lapses early.
- 2 fees due Sep 17 to 24, 2027 · next Sep 17
- 1 fee due Oct 9, 2027The maintenance fee for Optional Shaped Rectocele Paddles (US 11,951,034) comes due Oct 9, 2027. Unpaid by Apr 10, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,060,851 | Covering for an endoprosthetic device and methods of using for aneurysm treatment In force · From the USPTO record | In force | From the USPTO record | |
| US 9,452,210 | Influenza virus-like particles (VLPS) comprising hemagglutinin produced within a plant In force · From the USPTO record | In force | From the USPTO record | |
| US 9,458,470 | Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin In force · From the USPTO record | In force | From the USPTO record | |
| US 10,190,132 | Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin In force · From the USPTO record | In force | From the USPTO record | |
| US 8,015,256 | Method and Apparatus for Parallel Sequencing of Messages Between Disparate Information Systems In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 11,434,497 | Recombinant influenza virus-like particles (VLPS) produced in transgenic plants In force · From the USPTO record | In force | From the USPTO record | |
| US 8,551,165 | Cassette for intraocular lens and preloaded lens injection system In force · From the USPTO record | In force | From the USPTO record | |
| US 9,492,528 | Influenza virus-like particles (VLPS) comprising hemagglutinin In force · From the USPTO record | In force | From the USPTO record | |
| US 10,272,148 | Chimeric Influenza Virus-Like Particles Comprising Hemagglutinin In force · High confidence | In force | High confidence | |
| US 8,852,590 | Compositions and Methods for Treating Cancer In force · High confidence | In force | High confidence |
Also on record, not counted in the 86: 65 lapsed for an unpaid fee · 123 ended at full term · 1 surrendered on reissue. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 6 abandoned · 67 no status recorded